Literature DB >> 26077561

Is the association of hypertension with cardiovascular events stronger among the lean and normal weight than among the overweight and obese? The multi-ethnic study of atherosclerosis.

Laura A Colangelo1, Thanh-Huyen T Vu2, Moyses Szklo2, Gregory L Burke2, Christopher Sibley2, Kiang Liu2.   

Abstract

Previous studies that suggest the association of hypertension with cardiovascular disease (CVD) events is stronger in the lean/normal weight than in the obese have either included smokers, diabetics, or cancer patients, or did not account for central obesity. This study examines the interaction of adiposity with hypertension on CVD events using body mass index (BMI)-based definitions of overweight and obesity, as well as waist circumference (WC) to assess adiposity. In the Multi-Ethnic Study of Atherosclerosis, we classified 3657 nonsmoking men and women, free of baseline clinical CVD, diabetes mellitus and cancer, into 7 BMI-WC combinations defined by ethnicity-specific BMI (normal, overweight, class 1 obese, and class 2/3 obese) and ethnicity- and sex-specific WC categories (optimal or nonoptimal). Adjusted absolute event rates per 1000 person-years and relative risks (95% confidence intervals) for CVD events for hypertension (blood pressure ≥140/90 or taking medication) versus no hypertension computed within adiposity categories were 9.3 versus 1.9 and 4.96 (2.56-9.60) for normal BMI/optimal WC, 13.2 versus 4.2 and 3.13 (0.99-9.86) for normal BMI/nonoptimal WC, 9.0 versus 4.5 and 2.00 (1.19-3.36) for overweight BMI/optimal WC, 8.4 versus 5.6 and 1.50 (0.88-2.54) for overweight BMI/nonoptimal WC,14.1 versus 2.1 and 6.75 (0.69-65.57) for class 1 obese/optimal WC, 10.1 versus 3.7 and 2.69 (1.41-5.16) for class 1 obese/nonoptimal WC, and 9.9 versus 6.9 and 1.45(0.60-3.52) for class 2/3 obese/WC pooled. This study found a large relative risk of CVD events associated with hypertension for normal BMI participants and more importantly similarly high absolute risks for both normal and obese BMI with hypertension.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  blood pressure; cardiovascular disease; follow-up studies; hypertension; obesity; risk; waist circumference

Mesh:

Year:  2015        PMID: 26077561      PMCID: PMC4828916          DOI: 10.1161/HYPERTENSIONAHA.114.04863

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  38 in total

Review 1.  Ectopic fat depots and cardiovascular disease.

Authors:  Kathryn A Britton; Caroline S Fox
Journal:  Circulation       Date:  2011-12-13       Impact factor: 29.690

2.  Assessing adiposity: a scientific statement from the American Heart Association.

Authors:  Marc-Andre Cornier; Jean-Pierre Després; Nichola Davis; Daurice A Grossniklaus; Samuel Klein; Benoit Lamarche; Francisco Lopez-Jimenez; Goutham Rao; Marie-Pierre St-Onge; Amytis Towfighi; Paul Poirier
Journal:  Circulation       Date:  2011-09-26       Impact factor: 29.690

Review 3.  Genetic basis of blood pressure and hypertension.

Authors:  Sandosh Padmanabhan; Christopher Newton-Cheh; Anna F Dominiczak
Journal:  Trends Genet       Date:  2012-05-21       Impact factor: 11.639

4.  Prediction of blood pressure changes over time and incidence of hypertension by a genetic risk score in Swedes.

Authors:  Cristiano Fava; Marketa Sjögren; Martina Montagnana; Elisa Danese; Peter Almgren; Gunnar Engström; Peter Nilsson; Bo Hedblad; Gian Cesare Guidi; Pietro Minuz; Olle Melander
Journal:  Hypertension       Date:  2012-12-10       Impact factor: 10.190

Review 5.  Exploring gene-environment relationships in cardiovascular disease.

Authors:  Philip G Joseph; Guillaume Pare; Sonia S Anand
Journal:  Can J Cardiol       Date:  2013-01       Impact factor: 5.223

6.  Mortality from ischaemic heart disease: age-specific effects of blood pressure stratified by body-mass index: the HUNT cohort study in Norway.

Authors:  Bjørn Mørkedal; Pål R Romundstad; Lars J Vatten
Journal:  J Epidemiol Community Health       Date:  2010-05-12       Impact factor: 3.710

Review 7.  New insights into the true nature of the obesity paradox and the lower cardiovascular risk.

Authors:  Steven G Chrysant; George S Chrysant
Journal:  J Am Soc Hypertens       Date:  2013 Jan-Feb

8.  Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension.

Authors:  Elisabeth Lambert; Nora Straznicky; Markus Schlaich; Murray Esler; Tye Dawood; Elodie Hotchkin; Gavin Lambert
Journal:  Hypertension       Date:  2007-10-01       Impact factor: 10.190

9.  Obesity paradox in patients with hypertension and coronary artery disease.

Authors:  Seth Uretsky; Franz H Messerli; Sripal Bangalore; Annette Champion; Rhonda M Cooper-Dehoff; Qian Zhou; Carl J Pepine
Journal:  Am J Med       Date:  2007-10       Impact factor: 4.965

10.  Does obesity modify the effect of blood pressure on the risk of cardiovascular disease? A population-based cohort study of more than one million Swedish men.

Authors:  Karri Silventoinen; Patrik K E Magnusson; Martin Neovius; Johan Sundström; G David Batty; Per Tynelius; Finn Rasmussen
Journal:  Circulation       Date:  2008-09-29       Impact factor: 29.690

View more
  9 in total

1.  Evaluating Public Health Interventions: 6. Modeling Ratios or Differences? Let the Data Tell Us.

Authors:  Donna Spiegelman; Tyler J VanderWeele
Journal:  Am J Public Health       Date:  2017-07       Impact factor: 9.308

2.  Prevalence of Hypertension and Associated Factors among the Outpatient Department in Akaki Kality Subcity Health Centers, Addis Ababa, Ethiopia.

Authors:  Tadesse Bedada Haye; Berhanu Tolera Agama
Journal:  Int J Hypertens       Date:  2020-08-18       Impact factor: 2.420

3.  Construction of a risk assessment model of cardiovascular disease in a rural Chinese hypertensive population based on lasso-Cox analysis.

Authors:  Nanxiang Ouyang; Guangxiao Li; Chang Wang; Yingxian Sun
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-12-09       Impact factor: 2.885

4.  Prevalence of metabolically unhealthy obesity, overweight, and normal weight and the associated risk factors in a southern coastal region, Iran (the PERSIAN cohort study): a cross-sectional study.

Authors:  Ghazal Zoghi; Roghayeh Shahbazi; Masoumeh Mahmoodi; Azim Nejatizadeh; Masoumeh Kheirandish
Journal:  BMC Public Health       Date:  2021-11-05       Impact factor: 3.295

5.  Associations between non-traditional lipid measures and risk for type 2 diabetes mellitus in a Chinese community population: a cross-sectional study.

Authors:  Qiaofeng Song; Xiaoxue Liu; Anxin Wang; Youxin Wang; Yong Zhou; Wenhua Zhou; Xizhu Wang
Journal:  Lipids Health Dis       Date:  2016-04-05       Impact factor: 3.876

6.  Is visceral adiposity a modifier for the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes?

Authors:  Ryotaro Bouchi; Norihiko Ohara; Masahiro Asakawa; Yujiro Nakano; Takato Takeuchi; Masanori Murakami; Yuriko Sasahara; Mitsuyuki Numasawa; Isao Minami; Hajime Izumiyama; Koshi Hashimoto; Takanobu Yoshimoto; Yoshihiro Ogawa
Journal:  Cardiovasc Diabetol       Date:  2016-01-21       Impact factor: 9.951

7.  Impact of body mass index on long-term blood pressure variability: a cross-sectional study in a cohort of Chinese adults.

Authors:  Haojia Chen; Ruiying Zhang; Qiongbing Zheng; Xiuzhu Yan; Shouling Wu; Youren Chen
Journal:  BMC Public Health       Date:  2018-10-22       Impact factor: 3.295

8.  Body Composition and Mortality in Mexican American Adults: Results from the National Health and Nutrition Examination Survey.

Authors:  Carrie R Howell; Tapan Mehta; Keisuke Ejima; Kirsten K Ness; Andrea Cherrington; Kevin R Fontaine
Journal:  Obesity (Silver Spring)       Date:  2018-08-01       Impact factor: 5.002

9.  Prevalence and Risk Factors of Elevated Blood Pressure and Elevated Blood Glucose among Residents of Kajiado County, Kenya: A Population-Based Cross-Sectional Survey.

Authors:  Anita Nyaboke Ongosi; Calistus Wilunda; Patou Masika Musumari; Teeranee Techasrivichien; Chia-Wen Wang; Masako Ono-Kihara; Charlotte Serrem; Masahiro Kihara; Takeo Nakayama
Journal:  Int J Environ Res Public Health       Date:  2020-09-23       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.